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Abstract
Background: Altered dosage of the transcription factor PAX6 causes multiple human eye pathophysiologies. PAX6+/2
heterozygotes suffer from aniridia and aniridia-related keratopathy (ARK), a corneal deterioration that probably involves a
limbal epithelial stem cell (LESC) deficiency. Heterozygous Pax6+/Sey-Neu (Pax6+/2) mice recapitulate the human disease and
are a good model of ARK. Corneal pathologies also occur in other mouse Pax6 mutants and in PAX77Tg/2 transgenics, which
over-express Pax6 and model human PAX6 duplication.
Methodology/Principal Findings: We used electron microscopy to investigate ocular defects in Pax6+/2 heterozygotes (low
Pax6 levels) and PAX77Tg/2 transgenics (high Pax6 levels). As well as the well-documented epithelial defects, aberrant Pax6
dosage had profound effects on the corneal stroma and endothelium in both genotypes, including cellular vacuolation,
similar to that reported for human macular corneal dystrophy. We used mosaic expression of an X-linked LacZ transgene in
X-inactivation mosaic female (XLacZTg/2) mice to investigate corneal epithelial maintenance by LESC clones in Pax6+/2 and
PAX77Tg/2mosaic mice. PAX77Tg/2mosaics, over-expressing Pax6, produced normal corneal epithelial radial striped patterns
(despite other corneal defects), suggesting that centripetal cell movement was unaffected. Moderately disrupted patterns in
Pax6+/2 mosaics were corrected by introducing the PAX77 transgene (in Pax6+/2, PAX77Tg/2 mosaics). Pax6Leca4/+, XLacZTg/2
mosaic mice (heterozygous for the Pax6Leca4 missense mutation) showed more severely disrupted mosaic patterns.
Corrected corneal epithelial stripe numbers (an indirect estimate of active LESC clone numbers) declined with age (between
15 and 30 weeks) in wild-type XLacZTg/2 mosaics. In contrast, corrected stripe numbers were already low at 15 weeks in
Pax6+/2 and PAX77Tg/2 mosaic corneas, suggesting Pax6 under- and over-expression both affect LESC clones.
Conclusions/Significance: Pax6+/2 and PAX77Tg/2 genotypes have only relatively minor effects on LESC clone numbers but
cause more severe corneal endothelial and stromal defects. This should prompt further investigations of the
pathophysiology underlying human aniridia and ARK.
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Introduction
The Pax6 gene encodes the Pax6 transcription factor with key
regulatory roles in eye development [1–5]. Abnormal expression
results in a spectrum of ocular pathophysiologies, some of which
are directly linked to the protein level [6–9]. Some corneal
abnormalities associated with Pax6 mutations occur during
development and others result from inadequate tissue mainte-
nance.
It is widely accepted that, during adult corneal epithelial
homeostasis, cell production is initiated by limbal epithelial stem
cells (LESCs) in the limbus at the corneoscleral junction [10–14].
LESCs proliferate to produce transient (or transit) amplifying cells
(TACs) that migrate centripetally, dividing a few times before
terminally differentiating. As TACs differentiate they lose contact
with the basal epithelium, move apically, and are desquamated
from the surface layer [15,16]. Epithelial abnormalities could be
caused by defects in LESCs or epithelial cell proliferation,
movement or loss.
Centripetal movement in the mouse corneal epithelium has
been demonstrated directly in several experimental systems
[17,18] and indirectly by the postnatal switch from a randomly
orientated mosaic pattern to radial stripes in X-inactivation
mosaics [19–21] and lentivirus-labelled lineages [22]. Radial
stripes emerging from the periphery and extending towards the
central cornea from ,5 weeks are thought to represent clones of
centripetally migrating epithelial cells produced after LESC
activation. Numerical analysis of these striping patterns provides
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an indirect estimate of the number of coherent clones of LESCs
maintaining the corneal epithelium [19–21].
Pax6 is widely expressed during eye development [23] and
continues in several adult tissues, including the corneal, limbal and
conjunctival epithelia [24]. Absence of Pax6 causes anophthalmia
in both mice [1] and humans [25]. Eye development is highly
sensitive to Pax6 dose and haploinsufficiency in human PAX6+/2
heterozygotes is characterised by aniridia and other ocular
abnormalities [26–28]. Heterozygosity for mouse Pax62 null
mutations, such as Pax6Sey [1,29,30], Pax6Sey-Neu [1,31] and Pax6LacZ
[32], causes similar abnormalities and small-eyes. Ocular pheno-
types produced by hypomorphic Pax6 alleles showed that surface
ectoderm derivatives are more sensitive to Pax6 levels than optic
vesicle derivatives [6]. PAX6 missense mutations often cause
different eye phenotypes from null mutations [33–35]. For
example, Pax6Leca4/+ heterozygous mice have small, abnormal
eyes with corneal vascularisation from fetal stages and pigmenta-
tion (but no goblet cells) within the cornea [36].
Pax6+/2 mice have corneal and other anterior segment
abnormalities [37–46] and some have been characterised by
electron microscopy (EM) [38,47,48]. The postnatal corneal
deterioration in Pax6+/2 mice is equivalent to that seen in human
aniridia-related keratopathy (ARK), which has been attributed to
LESC deficiency. This is based entirely on indirect evidence such
as the presence of goblet cells [49] and clinical results for limbal
transplants [50] because there are currently no suitable LESC
markers. Quantitative analysis of mosaic corneal epithelial
patterns in mouse X-inactivation mosaics and chimeras also
suggests that Pax6+/2 mice have fewer active clones of LESCs than
normal [51]. However, the stripe pattern is disrupted, implying
that cell movement is abnormal so Pax6+/2 corneal deterioration
probably involves additional factors.
Over-expression of Pax6 in hemizygous PAX77Tg/2 mice with
5–7 copies of human PAX6 [8] also causes eye abnormalities on a
wild-type (WT) background and provides a model for human
PAX6 gene duplication [7]. The abnormalities overlap with those
produced by heterozygous Pax6+/2 mice (low Pax6 levels) but
there are significant differences and genetic background modulates
the phenotype [8,52–55]. Pax6 levels are increased less than gene
copy numbers predict [52,54,55] but the PAX77 transgene can
rescue various Pax6+/2 and Pax62/2 ocular phenotypes [8].
The present study had three aims. (1) To investigate the effects
of altered Pax6 dose on the corneal stroma and endothelium in
Pax6+/2 and PAX77Tg/2 mice using EM, to complement previous
studies of effects on the corneal epithelium. (2) Given that our
previous clonal analysis of X-inactivation mosaics identified
abnormalities of corneal epithelial maintenance in Pax6+/2 mice
[51], to investigate whether Pax6 over-expression causes similar
abnormalities in PAX77Tg/2 mice. (3) To investigate whether this
effect can be rescued by combining the PAX77 transgene with a
Pax6+/2 genotype. We identified previously unreported corneal
endothelial and stromal abnormalities in both genotypes by EM.
Furthermore, our qualitative analysis of X-inactivation mosaics
implied that cell movement was normal during corneal epithelial
maintenance in PAX77Tg/2 mice (unlike Pax6+/2 heterozygotes)
and our quantification suggested that in younger mice LESC clone
numbers were reduced in both Pax6+/2 and PAX77Tg/2
genotypes. The PAX77 transgene normalised both the qualitative
and quantitative defects in Pax6+/2 corneas.
Results
We used scanning electron microscopy (SEM) and transmission
electron microscopy (TEM) to compare the structure of corneas
from WT, Pax6+/2 and PAX77Tg/2 mice. We also analysed mosaic
patterns in the corneal epithelia of WT, Pax6+/2 and PAX77Tg/2
X-inactivation mosaics to compare effects of Pax6 doses on
corneal epithelial cell movement (from mosaic patterns) and LESC
clone numbers (from quantitative analysis of corrected stripe
numbers).
PAX77Tg/2 corneal epithelial cells have abnormally large
microvilli and less pronounced cell junctions
On the CBA/Ca background Pax6+/2 and PAX77Tg/2 eyes
were smaller than WT (Fig. 1A–C) and PAX77Tg/2 mice had
microcorneas and a pronounced ring around the corneoscleral
junction (Fig. 1C). SEM of the superficial corneal epithelial cells
showed that, the WT corneal epithelium consisted of large
polygonal cells with tightly opposed cell junctions (Fig. 1D) and
numerous microvilli (Fig. 1G). Despite reported increased
sloughing of Pax6+/2 corneal epithelial cells [38], the epithelia of
the Pax6+/2 specimens analysed by SEM appeared similar to WT
(Fig. 1E,H). However, the PAX77Tg/2 epithelial cells had a more
irregular surface (Fig. 1F,I), indistinct cell junctions (Fig. 1F) and
larger microvilli (Fig. 1I). Other corneal epithelial abnormalities
have been well described, so further EM work focused on the
corneal stroma and endothelium. Previously unreported abnor-
malities are discussed below and summarised in Table 1.
Pax6+/2 and PAX77Tg/2 corneal endothelial cells are
severely abnormal
SEM examination revealed serious abnormalities in both Pax6+/2
and PAX77Tg/2 corneal endothelia. The WT corneal endothelial
cells were hexagonal (mean diameter, 18.762.35 mm; Fig. 2A,D)
whereas Pax6+/2 cells were larger (23.7563 mm; Fig. 2B,E) and
slightly irregularly shaped. The PAX77Tg/2 endothelium was
Figure 1. Electron microscopy of whole eyes and corneal
epithelium. A–C. SEM micrographs of (A) WT, (B) Pax6+/2 and (C)
PAX77Tg/2 eyes showing differences in size and gross morphology. Scale
bars = 500 mm. (Diameters of WT, Pax6+/2 and PAX77Tg/2 eyes used for
EM were approximately 2.9, 2.5 and 2.2 mm respectively and corneal
diameters (dome base diameters) were approximately 2.5, 2.3 and
1.6 mm respectively.) D–F. SEM micrographs of (D) WT, (E) Pax6+/2 and
(F) PAX77Tg/2 surfaces of corneal epithelial cells showing polygonal cell
shapes and cell junctions. The surface of the cells appears more
irregular in the PAX77Tg/2 corneas than WT. Scale bars = 10 mm. G–I.
Higher power SEM micrographs of (G) WT, (H) Pax6+/2 and (I) PAX77Tg/2
surfaces showing microvilli on cell surfaces. Microvilli are larger in the
PAX77Tg/2 corneas than WT. Scale bars = 5 mm.
doi:10.1371/journal.pone.0028895.g001
Effects of Pax6 Dosage on Mouse Cornea
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highly irregular with indistinct cell borders that were only visible
at higher magnification (Fig. 2C,F). The WT endothelial cells
had either no vacuoles or very small vacuoles (Fig. 2D,G),
whereas the Pax6+/2 and PAX77Tg/2 endothelial surfaces
appeared highly irregular by SEM (Fig. 2E,F) and TEM
revealed large intracellular vacuoles across the entire endothe-
lium in each case (Fig. 2H,I). In PAX77Tg/2 corneal endothelia
the vacuoles seemed smaller towards the central cornea (data
not shown). These results imply that Pax6 over- and under-
expression both produced significant endothelial defects but
over-expression produced a more severe phenotype.
Pax6+/2 and PAX77Tg/2 corneal stromas are abnormal
Marked abnormalities occurred in the corneal stromas of both
the Pax6+/2 and PAX77Tg/2 mice. TEM showed that keratocytes
in the WT stroma were normal with numerous cell organelles
(Fig. 3A) but Pax6+/2 keratocytes had large intracellular vacuoles
(Fig. 3B,C) and PAX77Tg/2 keratocytes had smaller vacuoles
(Fig. 3D). Subjectively both Pax6+/2 and PAX77Tg/2 stromas also
appeared to be more highly innervated with nerve cells (Fig. 3E,F)
than in the WT stroma but this was not quantified.
Over-expression of Pax6 in PAX77Tg/2 mice does not
disrupt corneal epithelial maintenance
To compare the effects of different Pax6 doses on corneal
epithelial maintenance by analysis of striped patterns in X-
inactivation mosaics, we crossed PAX77Tg/2 and Pax6+/2 females
to XLacZTg/Y males carrying the X-linked LacZ transgene and
analysed patterns in the corneal epithelia of XLacZTg/2 X-
inactivation mosaic females, as described elsewhere [19–21].
WT, XLacZTg/2 mosaics corneas showed radial striping patterns
(Fig. 4A,B) whereas Pax6+/2, XLacZTg/2 mosaics produced more
irregular patterns (Fig. 4C,D) as demonstrated previously
Table 1. Main new abnormalities in Pax6+/2 and PAX77Tg/2 corneas identified by electron microscopy.
Feature Wild-type Pax6+/2 PAX77Tg/2
Size of microvilli on surface of epithelial cells normal normal large
Intracellular vacuoles in stromal keratocytes none yes (large) yes (small)
Presence of nerve cells in stroma present more frequent* more frequent*
Intracellular vacuoles in corneal endothelium no yes yes
Corneal endothelial cell size and shape regular/hexagonal large/irregular indistinct boundaries
*Nerve cell numbers appeared more frequent in Pax6+/2 and PAX77Tg/2 corneal stromas but they were not quantified.
doi:10.1371/journal.pone.0028895.t001
Figure 2. Electron microscopy of corneal endothelium. A–C. SEM
micrographs of (A) WT, (B) Pax6+/2 and (C) PAX77Tg/2 corneal
endothelial cells. WT endothelial cells have a regular hexagonal shape,
Pax6+/2 cells have an irregular vacuolated appearance and are larger
than normal and PAX77Tg/2 endothelial cells have an irregular
vacuolated appearance, are irregular in shape and the cell borders
are difficult to resolve. Scale bars = 10 mm. D–F. Higher power SEM
micrographs of (D) WT, (E) Pax6+/2 and (F) PAX77Tg/2 corneal
endothelial cells showing that although both Pax6+/2 and PAX77Tg/2
corneal endothelial cells are vacuolated and irregular in shape the cell
borders are more distinct in Pax6+/2 cells. Scale bars = 10 mm. G–I. TEM
micrographs of (G) WT, (H) Pax6+/2 and (I) PAX77Tg/2 corneal endothelial
cells (shown above Descemet’s membrane and stroma) at the periphery
of the cornea. Pax6+/2 and PAX77Tg/2 endothelial cells contain large
vacuoles. Scale bars = 1 mm.
doi:10.1371/journal.pone.0028895.g002
Figure 3. Electron microscopy of corneal stroma. TEM micro-
graphs of (A) WT corneal stroma showing normal keratocyte
morphology with no vacuoles; (B,C) Pax6+/2 corneal stroma showing
keratocytes with very large vacuoles; (D) PAX77Tg/2 corneal stroma
showing keratocyte with small vacuoles; (E) Pax6+/2 corneal stroma
showing nerve cell; (F) PAX77Tg/2 corneal stroma showing nerve cell.
Abbreviations: *v, vacuole; *n, nerve cell. Scale bars = 500 nm in A–D
and 1 mm in E and F.
doi:10.1371/journal.pone.0028895.g003
Effects of Pax6 Dosage on Mouse Cornea
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[19,21,51]. Strikingly, despite corneal defects (Tables 1 and 2), the
PAX77Tg/2, XLacZTg/2 mosaic eyes exhibited a qualitatively
normal striped phenotype with radial stripes extending from the
limbal region (Fig. 4E,F), consistent with normal centripetal
movement from the presumptive LESCs. In contrast, the
Pax6Leca4/+, XLacZTg/2 mosaic corneal patterns appeared as an
abnormal mosaic patchwork rather than radial stripes (Fig. 4G,H),
so were not included in the quantitative analyses of stripe numbers
described below.
In sections of stained XLacZTg/2 corneas from WT, Pax6+/2
and PAX77Tg/2 animals, clones of b-gal positive cells were aligned
vertically with little overlap of b-gal positive and b-gal negative
cells (Fig. 5). We, therefore, treated the stripes as 2-dimensional
patterns and reduced them to a 1-dimensional count for
quantification (see Materials and Methods).
Over-expression of Pax6 in PAX77Tg/2 mosaic corneas
results in fewer corneal stripes
Although stripe patterns in PAX77Tg/2, XLacZTg/2 mosaics
appeared normal, a quantitative analysis was undertaken to
identify any subtle differences that might suggest that stem cell
clones were affected. The observed number of radial stripes in the
corneal epithelium was converted to a corrected stripe number to
compare LESC clone numbers between different groups (see
Materials and Methods). A preliminary experiment, using
PAX77Tg/2 mice on an outbred CD-1 genetic background showed
that the corrected stripe number per eye was significantly lower in
PAX77Tg/2, XLacZTg/2 mosaics than WT, XLacZTg/2 controls at
15 weeks (Table 3). This difference remained significant after
correcting for the smaller circumferences of PAX77Tg/2 corneas,
suggesting that PAX77Tg/2, XLacZTg/2 corneas were maintained
by fewer active LESC clones than normal.
Although the corrected stripe number does not provide a direct
estimate of LESC numbers, it can be used to compare LESC
clones between different groups of mice. The corrected stripe
number is an estimate of the number of corneal epithelial clones,
each of which will be produced by an active coherent clone of
LESCs in the limbus. A difference in corrected stripe number,
therefore, predicts a difference in the number of active LESC
clones and this could reflect a difference in active LESC numbers
and/or a change in the LESC distribution (number of LESCs per
clone).
The preliminary results were confirmed and extended in a second
experiment, using PAX77Tg/2 mice on an inbred CBA/Ca genetic
background and analysing corneas at both 15 and 30 weeks. The
mean corrected stripe number per eye (or per mm circumference)
was significantly lower in PAX77Tg/2, XLacZTg/2mosaics than WT,
XLacZTg/2 controls at 15 weeks (Fig. 6). It declined between 15 and
30 weeks in WT, XLacZTg/2 controls, as reported previously
[19,21], but no reduction occurred in the PAX77Tg/2, XLacZTg/2
mosaics, so by 30 days the PAX77Tg/2 corrected stripe number was
not significantly different from controls (Fig. 6C,D). This suggests
that PAX77Tg/2, XLacZTg/2 corneas were maintained by fewer
active LESC clones than normal at 15 weeks (as in the preliminary
experiment, Table 3) but, unlike WT, this did not decline further
between 15 and 30 weeks.
The PAX77 transgene normalises corneal circumference
and corneal epithelial maintenance in Pax6+/2
heterozygotes
The additional Pax6 expression produced by the PAX77Tg/2
transgene can rescue abnormal ocular phenotypes in Pax6+/2 mice
[8]. To determine whether the PAX77Tg/2 transgene could also
rescue the abnormal Pax6+/2 striped pattern in mosaics (implying
abnormal corneal epithelial maintenance; Fig. 4E,F), we under-
took a third experiment which compared striping patterns in the
four XLacZTg/2 mosaic genotypes produced by crosses of Pax6+/2
females and PAX77Tg/2, XLacZTg/Y males. The stripe patterns for
the three genotypes already examined in earlier experiments
(Fig. 4A–F) were reproduced at both 15 and 30 weeks in the third
experiment (Fig. 7A–C) although on the genetic background
produced by this three-way cross, mice over-expressing Pax6
(PAX77Tg/2, Pax6+/+, XLacZTg/2) had smaller corneas (Fig. 7C;
compare Figs. 6B and 8A). In PAX77Tg/2, Pax6+/2, XLacZTg/2
mosaics, where the PAX77 transgene is expressed in a Pax6+/2
Figure 4. Mosaic patterns in the corneal epithelium. Represen-
tative images of b-gal staining in the corneal epithelia of X-inactivation
mosaic eyes showing variation in mosaic patterns among the four
different genotypes: (A,B) WT, XLacZTg/2; (C,D) Pax6+/2, XLacZTg/2; (E,F)
PAX77Tg/2, XLacZTg/2 and (G,H) Pax6Leca4/+, XLacZTg/2. Scale bar = 1 mm.
doi:10.1371/journal.pone.0028895.g004
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genetic background, the corneal circumference was larger than in
Pax6+/2, XLacZTg/2 and PAX77Tg/2, XLacZTg/2 mosaics and not
significantly different from WT (Fig. 8A). Similarly, in PAX77Tg/2,
Pax6+/2, XLacZTg/2 mosaic eyes the striping pattern appeared
qualitatively normal (Fig. 7D), unlike the disrupted Pax6+/2
pattern (Fig. 7B). This indicates that normal centrifugal corneal
epithelial movement had been restored.
The PAX77 transgene restores corneal epithelial stripe
numbers in Pax6+/2, PAX77Tg/2 mice
Although the mosaic corneal stripe patterns appeared normal in
PAX77Tg/2, Pax6+/2, XLacZTg/2 mosaics (Fig. 7), the second
experiment shows that this may mask quantitative differences
(Fig. 6C,D). Thus, to investigate whether the striped pattern was
normalised quantitatively as well as qualitatively by the presence of
the PAX77 transgene in PAX77Tg/2, Pax6+/2, XLacZTg/2 mosaics,
we analysed the corrected stripe number per cornea for the four
genotypes at 15 and 30 weeks of age (Fig. 8). At 15 weeks,
corrected stripe numbers in PAX77Tg/2, Pax6+/2, XLacZTg/2
mosaics were not significantly different from WT, XLacZTg/2
mosaics, but were significantly higher than in either PAX772/2,
Pax6+/2, XLacZTg/2 or PAX77Tg/2, Pax6+/+, XLacZTg/2 mosaics
(Fig. 8B). The corrected stripe number later declined in both
PAX77Tg/2, Pax6+/2, XLacZTg/2 and WT, XLacZTg/2 mosaics and
by 30 weeks there were no significant differences among the four
genotypes. When results were expressed as corrected stripes per
mm of corneal circumference (Fig. 8C), the PAX77Tg/2, Pax6+/2,
XLacZTg/2 and WT, XLacZTg/2 mosaics again had more stripes
than the other genotypes at 15 weeks but these differences failed to
reach significance. Nevertheless, corrected stripe numbers in
PAX77Tg/2, Pax6+/2, XLacZTg/2 mosaics were quantitatively
similar to those in WT, XLacZTg/2 mosaics, suggesting that the
PAX77 transgene had rescued the low 15-week Pax6+/2 stripe
number (estimated LESC clone number) as well as the qualitative
mosaic pattern.
Discussion
This study identified new corneal abnormalities, particularly in
the stroma and endothelium, in both Pax6+/2 and PAX77Tg/2
mice, which respectively under- and over-express Pax6. Analysis of
mosaic corneal patterns showed cell movement during corneal
epithelial maintenance was affected in Pax6+/2 but not PAX77Tg/2
mice and implied that LESC clones were affected in both Pax6+/2
and PAX77Tg/2 mice at 15 weeks.
Morphological abnormalities of Pax6+/2 and PAX77Tg/2
corneas
The abnormally large microvilli and indistinct cell junctions of
PAX77Tg/2 corneal epithelial cells are consistent with fragility tests
suggesting cell adhesion may be affected [56]. Significant new
morphological abnormalities were identified in the corneal stroma
and endothelium of both Pax6+/2 and PAX77Tg/2 mice including
intracellular vacuoles. There is some evidence that Pax6 is
expressed weakly and transiently in the mouse fetal corneal
stroma [47,57] and chimera experiments imply that Pax6
Table 2. Comparison of maintenance of corneal epithelium in adult Pax6+/2 and PAX77Tg/2 mice with low and high doses of Pax6
respectively.
Feature Pax6+/2 PAX77Tg/2
Number of corneal epithelial cell layers Reduced [37,38] slightly reduced [54]
Fragility of corneal epithelium fragile [38] moderately fragile [56]
Cell proliferation in basal corneal epithelium increased [38,39] increased [54]
Corneal opacity and vascularisation yes [37,43] no [54,55]
Abnormal corneal epithelial wound healing yes [40,42,54] yes [54]
Goblet cells in basal corneal epithelium present [37] absent [54,55]
Mosaic pattern in corneal epithelia (15 & 30 weeks) disrupted [20]* normal*
Stripe number in mosaic corneal epithelia (15 weeks) reduced [20]* reduced*
Stripe number in mosaic corneal epithelia (,30 weeks) reduced (28 wks) [20] or normal (30 wks)* normal*
*Reported in the present study.
doi:10.1371/journal.pone.0028895.t002
Figure 5. Sections of b-gal-stained mosaic corneal epithelia.
Representative images of b-gal-stained corneal sections showing
vertical alignment of b-gal-positive epithelial cells across the full
thickness of the epithelium in eyes expressing various levels of Pax6.
(A,B) WT, XLacZTg/2; (C,D) Pax6+/2, XLacZTg/2 and (E,F) PAX77Tg/2,
XLacZTg/2. The higher frequency of b-gal-positive cells in XLacZTg/2,
Pax6+/2 corneal stromas (C,D) probably reflects the greater permeability
of the thin Pax6+/2 corneal epithelium to X-gal stain during whole-
mount staining. Scale bar = 100 mm.
doi:10.1371/journal.pone.0028895.g005
Effects of Pax6 Dosage on Mouse Cornea
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functions cell-autonomously in developing stromal keratocytes or
their progenitors [57]. However, it is not known whether the
keratocyte and endothelial abnormalities described here are
primary defects of altered Pax6 dose in these lineages or an
indirect effect mediated via another tissue. The corneal endothe-
lium controls corneal hydration and nutrition via fluid transport.
Excessive hydration may cause corneal stromal haze or corneal
oedema, as in some human corneal stromal dystrophies. Similar
corneal endothelial and stromal keratocyte vacuolation also occurs
in human macular corneal dystrophy [58,59]. If the corneal
endothelium and/or stroma of PAX6+/2 human aniridia patients
are affected like the Pax6+/2 mice described here, this might have
important clinical implications and could underlie some of the
abnormal phenotypes associated with aniridia-related keratopathy.
Effects of Pax6 on corneal epithelial cell movement and
maintenance
The normal radial striped corneal epithelial pattern of WT X-
inactivation mosaics was disrupted in Pax6+/2 mosaics, implying
that corneal epithelial cell movement is abnormal [51] but it is
unclear whether this is caused by some intrinsic abnormality or a
response to chronic wounding of a thin and fragile cornea.
Although maintenance of the PAX77Tg/2 corneal epithelium is not
entirely normal (Table 2), PAX77Tg/2 mosaics had completely
normal radial striped patterns, implying that centripetal cell
movement is unaffected by the higher Pax6 dose. In contrast, the
pattern in corneas of Pax6Leca4/+ mosaics resembled the randomly
orientated pattern of patches seen in young WT corneas before
stripes emerge. This suggests that movement of cells from the
limbus is severely reduced and that the Pax6Leca4/+corneal
epithelium may be maintained by proliferation from within the
epithelium, perhaps because of an extreme LESC deficiency. This
possibility has previously been suggested to explain a similar
phenotype in Dstncorn1/corn1 homozygotes [60].
Evidence for effects of Pax6 dose on limbal stem cell
clones
Our quantitative analysis of striped patterns in Pax6+/2 and
PAX77Tg/2 X-inactivation mosaics showed that, at 15 weeks, the
corrected stripe numbers were lower than in WT mosaics, even
after correcting for differences in corneal circumference, implying
that at this age there were fewer clones of active LESCs
maintaining the corneal epithelium. However, no such difference
was seen at 30 weeks because, by this age, the stripe number had
declined in WT mosaics but the stripe numbers did not decline
between 15 and 30 weeks in Pax6+/2 and PAX77Tg/2 mosaics.
The decline in corrected stripe number in WT XLacZ mosaics
implies that there is an age-related decline in active LESC clones.
This may reflect a decline in LESC numbers or activity but it
could also be explained by a drift in LESC clone distributions. If
LESCs can divide either symmetrically to produce one LESC and
one TAC or asymmetrically to produce either two LESCs or two
TACs then the pattern of active stem cell clones may follow a
pattern of neutral drift as suggested for some other stem cell
systems, including spermatogonial stem cells [61] and intestinal
crypts [62,63]. Over time, stem cells may be lost and replaced by
their neighbours. On this basis, clones of stem cells will expand
and contract stochastically and some clones will be lost (e.g. if a b-
gal negative LESC clone, that is flanked by two b-gal positive
clones, is lost the b-gal negative stripe will be lost and the two
flanking b-gal positive stripes will merge into one larger one).
The lower corrected stripe number in Pax6+/2 and PAX77Tg/2
XLacZ mosaics compared to WT mosaics at 15 weeks can be
explained in several ways. It is possible that there are initially fewer
LESC clones in Pax6+/2 and PAX77Tg/2 eyes, either because
fewer LESCs are specified, or activated or because the LESCs are
grouped into fewer larger clones. Alternatively, LESC clone
numbers may initially be similar in all groups (before 15 weeks) but
the decline may begin earlier or be more rapid in Pax6+/2 and
PAX77Tg/2 mice, so by 15 weeks the LESC clone number is
similar to that in a 30 week WT mouse. It is not clear why the
Pax6+/2 and PAX77Tg/2 LESC clone numbers do not continue to
decline after 15 weeks, but it has been suggested that this might be
related to a minimum required for corneal epithelial maintenance
[21]. Regardless of the explanation it is clear that, at 15 weeks,
LESC clones numbers and/or distributions are different in Pax6+/2
and PAX77Tg/2 mice. However, as this difference is no longer
detectable at 30 weeks the difference is short-lived and may have
little biological significance.
The presence of goblet cells in the human corneal epithelium is
often cited as evidence of LESC deficiency [49,64]. However, the
quantitative analysis of Pax6+/2 and PAX77Tg/2 mosaics indicates
LESC clones are similarly affected in both genotype at 15 weeks
(Fig. 8B,C) but only Pax6+/2 mice have goblet cells in the corneal
epithelium (Table 2). This difference highlights the need for
reliable LESC markers.
The PAX77 transgene compensates for defects of corneal
maintenance in Pax6+/2 X-inactivation mosaics
On a Pax6+/2 background, the PAX77 transgene rescued the
abnormal stripe patterns that normally occur in Pax6+/2
heterozygotes and are attributed to low Pax6 levels. Quantitative
analysis showed that the PAX77 transgene also normalised the
putative deficiency in active stem cell clones (reduced stripe
number) that occurs in Pax6+/2 heterozygotes at 15 weeks. These
results imply that restoring the Pax6 dose to a more normal level
corrects abnormalities of corneal cell maintenance as well as the
developmental ocular defects demonstrated previously [8].
It is widely believed that stem cell deficiency causes most corneal
abnormalities in ARK. However, our quantitative analyses of
mosaic patterns suggest that Pax6+/2 and PAX77Tg/2 mice have
only relatively modest reductions in LESC clone numbers. In
contrast, both Pax6+/2 and PAX77Tg/2 mice have severe corneal
Table 3. Preliminary comparison of corrected stripe number in corneal epithelia of wild-type, XLacZTg/2 and PAX77Tg/2, XLacZTg/2
X-inactivation mosaics at 15 weeks.
Wild-type PAX77Tg/2 Significance (t-test)
Number of eyes 27 16
Corrected stripe number per eye (mean 6SEM) 79.9763.65 54.0763.43 P,0.0001
Corrected stripe number per mm corneal circumference 7.6560.35 5.9360.45 P=0.005
doi:10.1371/journal.pone.0028895.t003
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endothelial and stromal defects. This should prompt further
investigations of the pathophysiology underlying ARK.
Materials and Methods
Consumables were purchased from Sigma (Poole, UK) and
procedures carried out at room temperature, unless stated
otherwise.
Ethics statement
All animal work was approved by a University of Edinburgh
internal ethics committee and was performed in accordance with
institutional guidelines under license by the UK Home Office
(project license number PPL 60/3635).
Animals and genetic crosses
Mice were maintained in animal facilities of the College of
Medicine and Veterinary Medicine, University of Edinburgh.
Heterozygous Pax6+/Sey-Neu mice (abbreviated to Pax6+/2) and
wild-type (WT, Pax6+/+) littermates were produced from Pax6+/+
female6Pax6+/2 male crosses on a CBA/Ca genetic background
and genotyped by PCR as described previously [3]. Heterozygous
Pax6Leca4/+ mice, on a mixed genetic background, were provided
by Prof. Ian Jackson and Dr Sally Cross (MRC, Human Genetics
Unit, Edinburgh) and maintained as a closed, random-bred colony
by crossing Pax6Leca4/+ and WT mice within the colony. Outbred
CD-1 mice carrying the PAX77 transgene which expresses 5–7
copies of the human PAX6 gene [8] were provided by Professor
Veronica van Heyningen and Dr Dirk A. Kleinjan (MRC Human
Genetics Unit, Edinburgh) and the transgene was transferred to
the inbred CBA/Ca strain by genetic crosses as reported
previously [55]. In the present study we designated mice
hemizygous for the PAX77 transgene as PAX77Tg/2 (because the
use of ‘Tg’ to designate presence of the transgene is less ambiguous
than ‘+’ used in our previous ‘PAX77+/2’ notation [55]) and we
designate non-transgenic littermates as PAX772/2. The founder
colony is designated CD1-PAX77Tg and was maintained by CD-1
6 CD1-PAX77Tg/2 crosses. The derived congenic stock is
Figure 6. Quantitative comparisons of PAX77Tg/2 XLacZTg/2 and
PAX772/2 XLacZTg/2 eyes at 15 and 30-weeks. (A) WT Eye mass
increased significantly between 15 and 30 weeks (2-way ANOVA P,
0.0001, results of relevant post-hoc tests are shown in the figure). (B)
Corneal circumference differed significantly between WT and PAX77Tg/2
at 15 and 30 weeks but the increase in circumference between 15 and 30
weeks was only significant for WT (2-way ANOVA P,0.0001, results of
relevant post-hoc tests are shown in the figure). (C) The mean corrected
stripe number was significantly higher in the 15-week WT corneas than
the 30-week WT or 15-week PAX77Tg/2 groups, there was a significant
decline in stripe number between 15 and 30 weeks in the WT but not the
PAX77Tg/2 group (2-way ANOVA P,0.0001, results of relevant post-hoc
tests are shown in the figure). (D) The mean corrected stripe number was
significantly higher in the 15-week WT corneas than the 30-week WT or
15-week PAX77Tg/2 groups, there was a significant decline in stripe
number between 15 and 30 weeks in the WT but not the PAX77Tg/2
group (2-way ANOVA P,0.0001, results of relevant post-hoc tests are
shown in the figure). For each comparison there were 14–36 eyes per
group: 22 15-week WT, 36 30-week WT, 14 15-week PAX77Tg/2 and 20 30-
week PAX77Tg/2. Significant P-values for Tukey’s HSD post-hoc tests are
shown: ns = not significant; *P,0.05; **P,0.01; ***P,0.001;
****P,0.0001. For all post-hoc tests see Tables S1, S2, S3, S4.
doi:10.1371/journal.pone.0028895.g006
Figure 7. Representative images of b-gal staining in the corneal
epithelia of X-inactivation mosaic eyes expressing different
levels of Pax6. (A) WT (PAX772/2, Pax6+/+, XLacZTg/2) eyes exhibit
ordered radial stripes of clonally related epithelial cells. (B) PAX772/2,
Pax6+/2, XLacZTg/2 eyes are smaller and striping patterns are disrupted,
normal radial stripes are only rarely observed. (C) In eyes over-
expressing PAX6 (PAX77Tg/2, Pax6+/+, XLacZTg/2) the corneal epithelial
diameter is smaller in comparison to the overall eye size (microcornea)
but normal radial stripe patterns are visible. (D) PAX77Tg/2, Pax6+/2,
XLacZTg/2 corneas appear normal both in size and striping phenotype.
Scale bar = 1 mm.
doi:10.1371/journal.pone.0028895.g007
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designated CBA-PAX77Tg and was maintained by CBA/Ca 6
CBA-PAX77Tg/2 crosses. Hemizygous PAX77Tg/2 mice and WT,
PAX772/2 littermates were genotyped by PCR as described
previously [55]. No homozygous PAX77Tg/Tg transgenic mice were
used in this study.
H253 strain mice [65], ubiquitously expressing the Tg(Hmgcr-
lacZ)H253Sest, X-linked nLacZ transgene (abbreviated to XLacZ),
were obtained from the MRC Mammalian Genetics Unit,
Harwell, UK, as strain FTH, and maintained on a genetic
background that was predominantly a mixture of C57BL/6 and
CBA/Ca inbred strains. Males and females hemizygous for this X-
linked transgene are designated respectively XLacZTg/Y and
XLacZTg/2; female homozygotes are designated XLacZTg/Tg. X-
inactivation mosaics hemizygous for the Pax6Sey-Neu null mutation
and the Pax6Leca4 missense mutation, plus WT littermate controls,
were produced from Pax6+/2 female 6 XLacZTg/Y male and
Pax6Leca4/+ female6XLacZTg/Y male crosses respectively.
In a preliminary experiment, PAX77Tg/2, XLacZTg/2 and WT
control PAX772/2, XLacZTg/2 X-inactivation mosaic females were
produced using the original CD1-PAX77Tg stock in XLacZTg/Tg
female 6 CD1-PAX77Tg/2 male and CD1-PAX77Tg/2 female 6
XLacZTg/Y male crosses. Once the PAX77Tg/2 transgene had been
bred onto the CBA/Ca genetic background, female PAX77Tg/2,
XLacZTg/2 and PAX77Tg/2, XLacZTg/2 littermates were produced
from crosses between CBA-PAX77Tg/2 females and hemizygous
XLacZTg/Y males for a second experiment. In a third experiment,
crosses between Pax6+/2 females and hemizygous CBA-PAX77Tg/2,
XLacZTg/Y males were used to produce 4 types of XLacZTg/2,
X-inactivation mosaic females: (1) PAX77Tg/2, Pax6+/2, XLacZTg/2;
(2) PAX77Tg/2, Pax6+/+, XLacZTg/2; (3) PAX772/2, Pax6+/2,
XLacZTg/2 and (4) PAX772/2, Pax6+/+, XLacZTg/2.
Electron microscopy
Eyes from adult (8–22 weeks old) Pax6+/Sey-Neu (Pax6+/2) and
WT (Pax6+/+) littermates plus PAX77Tg/2 and WT (PAX772/2)
littermates, all on a CBA/Ca genetic background, were enucleated
and fixed in 2.5% (w/v) glutaraldehyde in 0.1 M sodium
cacodylate buffer prior to processing for scanning electron
microscopy as described elsewhere [59]. Whole eyes were washed
three times in cacodylate buffer for 15 minutes. Samples were
Figure 8. Quantitative comparison of stripe patterns in corneal
epithelia of X-inactivation mosaics of four genotypes. Corneal
circumferences and corrected stripe numbers were compared in WT
(PAX772/2, Pax6+/+, XLacZTg/2); Pax6+/2 (PAX772/2, Pax6+/2, XLacZTg/2);
PAX77Tg/2 (PAX77Tg/2, Pax6+/+, XLacZTg/2); and combined PAX77Tg/2,
Pax6+/2 (PAX77Tg/2, Pax6+/2, XLacZTg/2) mosaic eyes at both 15 and 30-
weeks. (A) The corneal circumference was significantly smaller in both
15-week and 30-week old PAX77Tg/2 (Pax6+/+, PAX77Tg/2, XLacZTg/2)
mice than in the three other genotypes at both ages (2-way ANOVA
P,0.0001, results of relevant post-hoc tests are shown in the figure). (B)
The Pax6+/2, PAX77Tg/2 corrected stripe number did not differ from WT
at 15 weeks. The WT corrected stripe number declined significantly
between 15 and 30 weeks. This was not the case for any other group.
(2-way ANOVA P,0.0001, results of relevant post-hoc tests are shown in
the figure). (C) On this genetic background correcting the mean
corrected stripe number for circumference abrogated the significant
results observed in B (2-way ANOVA P,0.01, but results of relevant
post-hoc tests were all non-significant). For each comparison there were
7–25 eyes per group: 25 15-week WT, 12 30-week WT, 20 15-week
Pax6+/2, 12 30-week Pax6+/2, 7 15-week PAX77Tg/2, 16 30-week
PAX77Tg/2, 22 15-week Pax6+/+, PAX77Tg/2 and 22 30-week Pax6+/+,
PAX77Tg/2 eyes. Significant P-values for Tukey’s HSD post-hoc tests are
shown: ns = not significant; *P,0.05; **P,0.01; ***P,0.001;
****P,0.0001. { P,0.0001 for differences with all other genotypes at
both ages. For all post-hoc tests see Tables S5, S6, S7.
doi:10.1371/journal.pone.0028895.g008
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post-fixed in 2% (w/v) osmium tetroxide for 3 hours and washed
again in cacodylate buffer before being passed through a graded
ethanol series.
For scanning electron microscopy (SEM), samples were
transferred to hexamethyldisilazane (HMDS) for 40 minutes and
air-dried. The samples were mounted on aluminium stubs and
sputter coated with gold using an Edwards S150A sputter coater
then examined on a JEOL JSM 5600 scanning electron
microscope.
For transmission electron microscopy (TEM), samples were
transferred to propylene oxide twice for 20 minutes each time.
They were placed in a solution containing 50% propylene oxide
and 50% Araldite resin (Agar Scientific, UK) overnight, after
which they were transferred to 100% resin and infiltrated
overnight under agitation. The samples were embedded in moulds
containing fresh resin and polymerised at 60uC for 24–36 hours.
Ultra-thin sections (50–70 nanometres thick) were cut on a
Reichert Ultracut E microtome, collected on naked copper grids
and counterstained for 1 hour each with 1% vanadyl sulphate and
phosphotungstic acid and then 15 minutes with Reynolds’ lead
citrate prior to examination on a JEOL JEM 1010 transmission
electron microscope.
Clonal analysis of X-inactivation striping patterns
X-gal staining of XLacZTg/2 eyes and the acquisition of images
have been described previously [19,21]. Striping patterns were
analysed automatically as described in Mort [66]. Photographs of
eyes were taken so that the entire cornea was visible and were
then cropped to the edge of the corneal epithelium and analysed
using ImageJ, a freeware software package designed by Wayne
Rasband for the National Institute of Health (NIH), USA (http://
rsb.info.nih.gov/ij/). The observed number of radial stripes in the
corneal epithelium was corrected for the probability that stripes
would contain multiple adjacent b-gal-positive corneal epithelial
clones. This involved dividing the observed mean width by the
function 1/(1-p), where p is the proportion of b-gal-positive cells
around the circumference as described previously [19–21]. The
corrected stripe number provides an estimate of the total number
of active corneal epithelial coherent clones (both b-gal positive
and b-gal negative) per circumference. This is useful for
comparing numbers of active clones of stem cells between
different groups but because the number of stem cells per
coherent clone may vary it is not a direct estimate of the number
of active stem cells. For the preliminary experiment mosaic
corneal patterns were analysed manually at 15 weeks using
Adobe Photoshop software as described previously [19]. For later
mosaic analyses performed at both 15 and 30 weeks, the ImageJ
plugin ‘Clonal Tools’ [66] was used in batch mode to analyse all
the images automatically. Where correction for the actual
circumference was required this was calculated by dividing the
number of corrected stripes by the circumference of each eye
measured using ImageJ.
Histology
Whole eyes dissected at 15 and 30 weeks after birth were fixed
and stained for b-gal reporter activity using X-gal as described
previously [19,21]. X-gal stained eyes were embedded in paraffin
wax and 7 mm sections were cut on a microtome, mounted on
standard microscope slides and counterstained with eosin and
neutral red as described previously [21].
Statistics
2-way ANOVAs and Tukey’s HSD post-hoc tests were
calculated using R statistical software (http://www.r-project.org/).
Student’s t-tests were calculated using Microsoft Excel.
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